NCT03631173 2025-03-25
MINIMUM
Oslo University Hospital
Phase NA Active not recruiting
Clinical Trials
7 trialsNCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT04281667 2022-11-17
MOBILE2
Helsinki University Central Hospital
Phase 4 Active not recruiting
NCT04003181 2021-09-08
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
University of Aarhus
Phase NA Completed
NCT03563586 2020-09-11
MECCA
National and Kapodistrian University of Athens
Phase NA Unknown
NCT03436719 2019-03-05
Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.
State Scientific Centre of Coloproctology, Russian Federation
Phase NA Unknown
NCT01931150 2017-01-13
Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT
Memorial Sloan Kettering Cancer Center
Phase 3 Completed